CytoDyn will hold a webcast on December 29, 2022 at 8:00 a.m. Pacific Time to discuss the performance of leronlimab in its clinical trials and the recent charges against its former CEO Nader Pourhassan, who was previously terminated on January 24, 2022, and has had no affiliation with the Company since that time.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CYDY:
